In the last 12 months, insiders at NeuroSense Therapeutics Ltd. ($NRSN) filed 3 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
NeuroSense Therapeutics Ltd. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Russek-Blum Niva (Chief Technology Officer) — 1 transaction totaling $0
- Binder Hagit (General Manager) — 1 transaction totaling $0
- Eisenberg Or (Chief Financial Officer) — 1 transaction totaling $0
View all SEC Filings for NeuroSense Therapeutics Ltd. (NRSN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Eisenberg Or | Chief Financial Officer | A | Ordinary Shares | 200000 | $0.00 | 1,254,050.0000 | 25,481,343 | 18.97% | 0.78% |
| March 26, 2026 | Russek-Blum Niva | Chief Technology Officer | A | Ordinary Shares | 200000 | $0.00 | 467,953.0000 | 25,481,343 | 74.64% | 0.78% |
| March 26, 2026 | Binder Hagit | General Manager | A | Ordinary Shares | 200000 | $0.00 | 521,806.0000 | 25,481,343 | 62.15% | 0.78% |